Edition:
United Kingdom

AnaptysBio Inc (ANAB.OQ)

ANAB.OQ on NASDAQ Stock Exchange Global Select Market

81.25USD
18 Oct 2018
Change (% chg)

-- (--)
Prev Close
$81.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
151,047
52-wk High
$134.00
52-wk Low
$60.80

Chart for

About

AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro,... (more)

Overall

Beta: --
Market Cap(Mil.): $725.82
Shares Outstanding(Mil.): 20.34
Dividend: --
Yield (%): --

Financials

  ANAB.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -1.06 -- --
ROI: -23.31 0.45 14.28
ROE: -48.33 1.37 16.00

BRIEF-Anaptysbio Qtrly Loss Per Share $0.63

* ANAPTYSBIO ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES PIPELINE UPDATES

08 May 2018

Earnings vs. Estimates